Roche (Nutley, NJ) recently announced that the FDA has approved labeling for use of the prescription weight-loss medication Xenical (orlistat) in the management of obese adolescents aged 12 to 16 years. This approval offers physicians and parents of overweight and obese adolescents a safe and effective treatment option to help manage their weight. Xenical works locally in the stomach to prevent dietary fat absorption by approximately 30%. It helps the patient lose weight as well as maintain the weight loss. For more information, visit www.xenical.com.
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs